@article{4f26bba8ce2d445e8fa0df363edfc295,
title = "Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors",
abstract = "An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.",
keywords = "TMP mimetic peptide, epidemiology, immune thrombocytopenic purpura, splenectomy, thrombosis, TMP mimetic peptide, epidemiology, immune thrombocytopenic purpura, splenectomy, thrombosis",
author = "M. Ruggeri and A. Tosetto and F. Palandri and N. Polverelli and Mazzucconi, {M. G.} and C. Santoro and G. Gaidano and M. Lunghi and F. Zaja and {De Stefano}, Valerio and R. Sartori and P. Fazi and F. Rodeghiero",
year = "2014",
doi = "10.1111/jth.12636",
language = "English",
volume = "12",
pages = "1266--1273",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7836",
publisher = "Elsevier B.V.",
}